July 30, 2025DiagnosticsOpen Access

Pancreatic Cancer Resectability After Neoadjuvant Treatment: An Imaging Challenge

View Full Paper

Ask AI

Bookmark

Main finding shows conventional imaging does not reliably predict pancreatic cancer resectability after neoadjuvant therapy.
Key evidence indicates tumor-vessel interface changes and CA 19-9 levels better correlate with surgical outcomes.
Approach involved reviewing studies on imaging roles post-neoadjuvant therapy for non-metastatic pancreatic cancer.
Significance lies in transitioning from static imaging criteria to dynamic assessments for improved patient outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Literature review examines resectability prediction in pancreatic cancer, suggesting dynamic imaging criteria and CA 19-9 enhance evaluation.

Christofilis et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Literature review examines resectability prediction in pancreatic cancer, suggesting dynamic imaging criteria and CA 19-9 enhance evaluation.